Our website uses cookies to distinguish you from other users of our website to provide you with the most relevant experience by remembering your preferences and repeat visits. By clicking on ‘Accept’ you consent to our cookie policy. However, you may visit ‘Cookie Settings’ to provide a controlled consent.

Accept

News

Archive

Resolve Therapeutics and Institut Pasteur collaborate to identify Cell-Free RNA triggers in autoimmunity Novadip announces the implantation of the first two patients in its phase 3 pivotal trial of NVD003 in CPT Antevia Networks and Benetel sign strategic partnership to accelerate scalable, mission-critical outdoor private 5G NorthSea Therapeutics announces achievement of key regulatory milestones for Orziloben Hitachi Energy and Pakal Technologies join forces in breakthrough silicon power semiconductor for high-voltage modules biomodal and Element Biosciences combine duet multiomic and high-throughput sequencing capabilities to advance clinical research
Back To News
Ception
October 17, 2017

Ception

Acquired by Cephalon. Focused on the development of a biologic therapy for the treatment of asthma.

Cookie Policy Website powered by 100% renewable energy Privacy Policy